PURPOSE: To evaluate the T1rho (T(1rho)) MRI relaxation time in hippocampus in the brain of Alzheimer's disease (AD), mild cognitive impairment (MCI), and control, and to determine whether the T(1rho) shows any significant difference between these cohorts. MATERIALS AND METHODS: With informed consent, AD (n = 49), MCI (n = 48), and age-matched control (n = 31) underwent T(1rho) MRI on a Siemens 1.5T Scanner. T(1rho) values were automatically calculated from the left and right hippocampus region using in-house developed software. Bonferroni post-hoc multiple comparisons was performed to compare the T(1rho) value among the different cohorts. RESULTS: Significantly higher T(1rho) values were observed both in AD (P = 0.000) and MCI (P = 0.037) cohorts compared to control; also, the T(1rho) in AD was significantly high over (P = 0.032) MCI. Hippocampus T(1rho) was 13% greater in the AD patients than control, while in MCI it was 7% greater than control. Hippocampus T(1rho) in AD patients was 6% greater than MCI. CONCLUSION: Higher hippocampus T(1rho) values in the AD patients might be associated with the increased plaques burden. A follow-up study would help to determine the efficacy of T(1rho) values as a predictor of developing AD in the control and MCI individuals.
PURPOSE: To evaluate the T1rho (T(1rho)) MRI relaxation time in hippocampus in the brain of Alzheimer's disease (AD), mild cognitive impairment (MCI), and control, and to determine whether the T(1rho) shows any significant difference between these cohorts. MATERIALS AND METHODS: With informed consent, AD (n = 49), MCI (n = 48), and age-matched control (n = 31) underwent T(1rho) MRI on a Siemens 1.5T Scanner. T(1rho) values were automatically calculated from the left and right hippocampus region using in-house developed software. Bonferroni post-hoc multiple comparisons was performed to compare the T(1rho) value among the different cohorts. RESULTS: Significantly higher T(1rho) values were observed both in AD (P = 0.000) and MCI (P = 0.037) cohorts compared to control; also, the T(1rho) in AD was significantly high over (P = 0.032) MCI. Hippocampus T(1rho) was 13% greater in the ADpatients than control, while in MCI it was 7% greater than control. Hippocampus T(1rho) in ADpatients was 6% greater than MCI. CONCLUSION: Higher hippocampus T(1rho) values in the ADpatients might be associated with the increased plaques burden. A follow-up study would help to determine the efficacy of T(1rho) values as a predictor of developing AD in the control and MCI individuals.
Authors: M Bobinski; J Wegiel; M Tarnawski; M Bobinski; B Reisberg; M J de Leon; D C Miller; H M Wisniewski Journal: J Neuropathol Exp Neurol Date: 1997-04 Impact factor: 3.685
Authors: Mohammad Haris; Anup Singh; Kejia Cai; Christos Davatzikos; John Q Trojanowski; Elias R Melhem; Christopher M Clark; Arijitt Borthakur Journal: J Neurol Date: 2010-10-07 Impact factor: 4.849
Authors: Shafik N Wassef; John Wemmie; Casey P Johnson; Hans Johnson; Jane S Paulsen; Jeffrey D Long; Vincent A Magnotta Journal: Mov Disord Date: 2015-03-29 Impact factor: 10.338
Authors: Mustapha Bouhrara; David A Reiter; Christopher M Bergeron; Linda M Zukley; Luigi Ferrucci; Susan M Resnick; Richard G Spencer Journal: Alzheimers Dement Date: 2018-04-19 Impact factor: 21.566
Authors: Mohammad Haris; Anup Singh; Kejia Cai; Erin McArdle; Matthew Fenty; Christos Davatzikos; John Q Trojanowski; Elias R Melhem; Christopher M Clark; Arijitt Borthakur Journal: J Neuroimaging Date: 2011-04 Impact factor: 2.486
Authors: Mustapha Bouhrara; Abinand C Rejimon; Luis E Cortina; Nikkita Khattar; Richard G Spencer Journal: Magn Reson Imaging Date: 2019-11-12 Impact factor: 2.546
Authors: Nana Owusu; Casey P Johnson; William Kearney; Dan Thedens; John Wemmie; Vincent A Magnotta Journal: NMR Biomed Date: 2019-11-19 Impact factor: 4.044